GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666,265 | -28.4% | 13,419 | -14.1% | 0.00% | -60.0% |
| Q2 2023 | $930,117 | +0.3% | 15,622 | -4.6% | 0.01% | +150.0% |
| Q1 2023 | $927,480 | -35.1% | 16,375 | -14.9% | 0.00% | -33.3% |
| Q4 2022 | $1,429,103 | +50.9% | 19,242 | +21.1% | 0.00% | +50.0% |
| Q3 2022 | $947,000 | -24.6% | 15,890 | -29.0% | 0.00% | -33.3% |
| Q2 2022 | $1,256,000 | -27.6% | 22,377 | -4.9% | 0.00% | -25.0% |
| Q1 2022 | $1,736,000 | +1.8% | 23,527 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $1,706,000 | -1.8% | 23,622 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $1,737,000 | +45.8% | 22,664 | +47.6% | 0.00% | +33.3% |
| Q2 2021 | $1,191,000 | +65.4% | 15,359 | +31.6% | 0.00% | +50.0% |
| Q1 2021 | $720,000 | -25.9% | 11,670 | -21.7% | 0.00% | -33.3% |
| Q4 2020 | $972,000 | +34.1% | 14,910 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $725,000 | +54.3% | 14,647 | +48.6% | 0.00% | +50.0% |
| Q2 2020 | $470,000 | +15.8% | 9,854 | +3.3% | 0.00% | 0.0% |
| Q1 2020 | $406,000 | – | 9,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |